Surpass Topical Anti Inflammatory Cream Patent Expiration

Exclusivity Information

Surpass Topical Anti Inflammatory Cream holds 1 exclusivity out of which 1 has expired. Details of Surpass Topical Anti Inflammatory Cream's exclusivity codes and their expiration dates are given below.

Drug Exclusivity Drug Exclusivity Expiration
NCE May 13, 2009

About Surpass Topical Anti Inflammatory Cream

Surpass Topical Anti Inflammatory Cream is a drug owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. Surpass Topical Anti Inflammatory Cream uses Diclofenac Sodium as the active ingredient.

Active Ingredient:

Surpass Topical Anti Inflammatory Cream uses Diclofenac Sodium as the active ingredient. Check out other Drugs and Companies using Diclofenac Sodium ingredient.